Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Viral dynamics in patients on antiretroviral drugs
- A resting CD4+ T cell
- Resting/activated/infected CD4+ T cells
- NFkappaB sites in the HIV LTR
- Establishment/maintenance of latent reservoir
- Frequency of latently infected CD4+ T cells (1)
- Residual viremia and blips - HAART patients (1)
- Frequency of latently infected CD4+ T cells (2)
- Dynamics of the latent pool
- Archival WT/drug resistance in latent reservoir
- HIV evolution
- Persistence of drug resistant variants - example
- Assay for latent HIV in viremic patients
- Archived nevirapine resistance
- Residual viremia and blips - HAART patients (2)
- Analysis of residual viremia in HAART patients
- Results of residual viremia analysis
- Theories regarding the blips in HAART patients
- Analysis of blips with frequent sampling
- No new mutations during blips
- Blips don't represent elevations in viremia
- Additional source of residual viremia
- Detection of predominant plasma sequence (1)
- Detection of predominant plasma sequence (2)
- Why wasn't this phenomenon seen before?
- Predominant plasma clone (PPC)
- Characteristics of the PPC
- Hypothesis on the origin of the PPCs
- PPC and stability of the latent reservoir
- Latent reservoir is not replenished by replication
- Conclusions
Topics Covered
- Viral dynamics in patients on antiretroviral drugs
- CD4+ T-cells
- Response of resting T-cells to AG
- Establishment and maintenance of a latent reservoir
- Dynamics of the latent pool
- HIV evolution
- HAART
- Residual viremia and blips on patients on HAART
- The nature of blips
- Blips do not represent clinically significant elevations in viremia
- Characteristics of the PPC
- The latent reservoir is not replenished by ongoing viral replication in patients on HAART
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Siliciano, R. (2007, October 1). Viral reservoirs, latency and mechanisms of HIV persistence [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/YJLS3398.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Siliciano has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.